CURA — Curaleaf Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Curaleaf Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	C2021 December 31st	C2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-69.8	-56.8	-215	-265	-239
Depreciation
Deferred Taxes
Non-Cash Items	1.35	-59	102	105	116
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-14	28.6	-55.8	66	32
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-38.3	4.27	-58.3	46.4	75.3
Capital Expenditures	-82.1	-126	-172	-135	-70.3
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-122	-70.8	7.98	-85.2	-8.38
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities	-204	-197	-164	-220	-78.7
Financing Cash Flow Items	-0.395	-2.51	36.2	-13.8	-15.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	18.1	224	449	41.8	-67
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-224	31.2	226	-136	-71.4